跳至主要内容
临床试验/NL-OMON32536
NL-OMON32536已完成不适用

The influence of oral contraceptives on lamotrigine clearance in patients on lamotrigine in combination with valproic acid, carbamazepine or oxcarbazepine as compared to patients on lamotrigine only. - ltg/oc in combination therapy

Stichting Epilepsie Instellingen Nederland0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • women in the age of 18-40 years that use OC in a stable dose as well as a stable dose of 1)LTG and VPA, 2)LTG and CBZ, 3)LTG and OCB.

排除标准

  • Use of steroid hormones (other than OC) as well as pregnancy or the intention to conceive, current breastfeeding or having delivered in the nine months prior to the study. Patients with abnormal liver and/or renal function or with known gynaecological or psychiatric co morbidity will be excluded.

研究者

相似试验